With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Scientists have unveiled a groundbreaking method to test how thousands of active substances influence cellular metabolism ...

Targeted therapies for high-risk leukemia in children have yet to be developed, but scientists at Université de Montréal and its affiliated Institute for Research in Immunology and Cancer are working ...

Advances in Experimental Pharmacology and Drug Discovery have encountered a crucial but often overlooked challenge: gender inequality. Despite the pivotal ...

Scientists synthesized inaoside A from mushrooms, unlocking its bioactive potential for functional foods and medicines.

A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery ... was recently published in the journal Nature Communications.

The global health landscape is constantly challenged by the emergence and re-emergence of viral pathogens. While significant ...

Altermagnetism was first theorized in 2019 and experimentally confirmed in 2024 by researchers at Mainz University. It ...

This piece is part of a series that dives deeper into the most prevalent themes of this year’s iteration of our flagship research piece, Charting Disruption. Click to read.

Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.